1. Home
  2. EVEX vs TYRA Comparison

EVEX vs TYRA Comparison

Compare EVEX & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eve Holding Inc.

EVEX

Eve Holding Inc.

HOLD

Current Price

$3.13

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$31.37

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVEX
TYRA
Founded
2020
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
EVEX
TYRA
Price
$3.13
$31.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
8
Target Price
$6.88
$44.63
AVG Volume (30 Days)
1.1M
718.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
6.79
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.83
$6.42
52 Week High
$7.70
$33.99

Technical Indicators

Market Signals
Indicator
EVEX
TYRA
Relative Strength Index (RSI) 29.47 56.04
Support Level $2.98 $27.50
Resistance Level $3.19 $31.35
Average True Range (ATR) 0.21 2.49
MACD -0.02 -0.23
Stochastic Oscillator 16.44 65.09

Price Performance

Historical Comparison
EVEX
TYRA

About EVEX Eve Holding Inc.

Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment , a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: